Palantir Price Targets Diverge Before Earnings

Palantir price targets diverge as analysts split before August earnings, forcing traders to reassess positioning amid valuation and AI demand uncertainty.

July 27, 2026·1 min read
View all news articles
Flat-vector server stack with fractured shell on a cobalt-silver gradient illustrating Palantir price targets diverging.

KEY TAKEAWAYS

  • Oppenheimer reiterated Outperform and a $200 price target in a July 27 note.
  • Analyst targets cluster near $181-$191 but range from $70 to $255, highlighting valuation split.
  • Shares were down about 27% year to date as investors weigh Aug. 3 earnings.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Palantir Technologies Inc. (PLTR) heads into its Aug. 3 earnings report with diverging price targets as analysts split, leaving valuation and AI-driven commercial growth as central issues for investors weighing the stock’s next direction.

Analyst Targets and Valuation Debate

Oppenheimer reiterated an Outperform rating and maintained a $200 price target in a research note dated July 27, 2026. Citi analyst Tyler Radke also reaffirmed a Buy rating, trimming his target to the same level while raising earnings expectations. Radke projects fiscal 2027 sales growth of 53% and commercial revenue growth of 67%.

Street consensus shows average targets near $181 to $191, with individual estimates ranging from $70 to $255. This wide spread highlights the ongoing debate over Palantir’s valuation. The company is viewed as a polarizing AI name, with some investors cooling after a prior quarter that posted 85% revenue growth.

Market Moves and Earnings Focus

Palantir shares have fallen about 27% year to date, trading under pressure as investors weigh high expectations. The stock rose roughly 7% to about $131 in one session amid increased analyst attention.

Market participants are focused on the upcoming earnings report to see if sustained commercial AI demand and margin expansion can justify current valuation multiples. The report will test whether growth and profitability gains can support the stock’s price after recent declines.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

AST SpaceMobile Q2 Results Miss Estimates, Reaffirm Guidance

AST SpaceMobile Q2 Results Miss Estimates, Reaffirm Guidance

AST SpaceMobile Q2 results missed expectations; management reaffirmed 2026 revenue guidance and pointed to a $1.3B backlog as traders weigh cash burn risk.

Cardinal Health Earnings Lift Guidance on Specialty Drugs

Cardinal Health Earnings Lift Guidance on Specialty Drugs

Cardinal Health earnings raised full-year EPS guidance to $12.40 to $12.60 on specialty drug strength, likely prompting repositioning into specialty names.

Super Micro Earnings Preview: Margins and Backlog

Super Micro Earnings Preview: Margins and Backlog

Super Micro earnings preview noted 15%-17% gross margin and a record backlog, putting traders on watch for backlog conversion into revenue and AI demand.

Trump Media Earnings: Q2 Loss Deepens

Trump Media Earnings: Q2 Loss Deepens

Trump Media earnings said non-cash digital-asset writedowns pushed $238.1 million Q2 loss, magnifying asset-price volatility and prompting traders to trim stakes.

Nvidia $500 Billion AI Financing Deal

Nvidia $500 Billion AI Financing Deal

Nvidia $500 billion AI financing pact with six Wall Street firms aims to mobilize capital for compute and data centers and could reprice chip demand.

Hims & Hers Q2 2026 Results: Guidance Raised

Hims & Hers Q2 2026 Results: Guidance Raised

Hims & Hers Q2 2026 Results lifted full-year revenue and adjusted-EBITDA guidance after subscriber gains, sharpening trader focus on growth versus margins.